Navigation Links
Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results
Date:9/13/2010

BALTIMORE, Sept. 13 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal 2011 first quarter ended July 31, 2010.  Full details of the Company's financial results will be available in the Company's Form 10-Q at www.championsbiotechnology.com.

Total revenues for the first quarter of fiscal 2011 were $1.6 million compared to $962,000 in the first quarter of fiscal 2010, an increase of 66%.  Revenues from Personalized Oncology were $1.1 million compared to $899,000 in the corresponding quarter of the prior year, an increase of 23%.  Revenues from Preclinical eValuation were $491,000 for the quarter compared to $63,000 in the corresponding quarter of the prior year, an increase of 679%.  The increase in Preclinical eValuation was a result of the Company beginning to recognize revenues in its second full year of providing Preclinical services.

Cost of Personalized Oncology services for the first quarter of 2011 was $324,000 which resulted in a gross margin of 71% as compared to 29% in the corresponding 2010 fiscal quarter.  The increase in gross margin was due to a greater mix of higher-margin business.

Cost of Preclinical eValuation services for the first quarter of fiscal 2011 was $222,000 which resulted in a gross margin of 55% as compared to 46% in the corresponding 2010 fiscal quarter.  The increase in gross margin in 2011 resulted from increased pricing efficiencies realized in the Company's second full year of operations.

Research and development ("R&D") expenses for the first quarter of fiscal 2011 were $919,000 as compared to $496,000 in the first qua
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results
2. Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
3. Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
4. Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)
5. Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results
6. Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
7. Champions Biotechnology to Present at Rodman & Renshaws Eleventh Annual Healthcare Conference
8. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
9. Champions Biotechnology Reports Fiscal 2009 Full-Year Financial Results
10. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
11. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... (PRWEB) March 26, 2015 WriteResult, a ... with researchers from Yale University’s School of Public Health ... study participants during a 4 month-long project. The goal ... providing low income families with free access to fresh ... and diet-related health concerns like high blood pressure, diabetes ...
(Date:3/25/2015)... Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: ... with certain shareholders representing approximately 45% of the outstanding ... certain matters including the appointment of auditors at its ... 2015 (the "Meeting") it intends to adjourn the Meeting ... when the Meeting reconvenes. The Meeting will be reconvened ...
(Date:3/25/2015)... YORK , March 25, 2015  S&P ... commenced Factual Stock Report coverage on Abattis ... (OTCQX: ATTBF; CSE: ATT): is a specialty biotechnology ... of cultivating, licensing and marketing proprietary ingredients, bio-similar ... markets in North America . ...
(Date:3/25/2015)... CAMBRIDGE, Mass. and REYKJAVIK, Iceland ... comprehensive capabilities for using the genome to create better medicine, ... of the largest studies of whole-genome data yet undertaken. ... Nature Genetics – are built around the ... by a team of deCODE scientists led by Kari ...
Breaking Biology Technology:Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 2Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2
... SAN MATEO, Calif. , May 10 Nile ... the development of novel therapeutics for heart failure patients, today ... of units consisting of common stock and warrants have fully ... cover over-allotments. The additional units consisted of an aggregate of ...
... May 10 /PRNewswire-FirstCall/ - Mr. Richard Gilbertson ... IGEN ... an exclusive distribution license agreement with Machlink Inc. (MLI) for rights ... Internet. MLI,s,s unique technology, utilizing Ultra High Frequency ("UHF") spectrum, permits ...
... Neuralstem, Inc. (NYSE Amex: CUR ) CEO and President, Richard Garr ... and Regenerative Medicine Congress, held May 11-13 , in London, UK ... clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig ,s ... , , ...
Cached Biology Technology:Nile Therapeutics Announces Exercise of Over-Allotment Option for Recent Public Offering 2Nile Therapeutics Announces Exercise of Over-Allotment Option for Recent Public Offering 3IGEN Networks signs Exclusive Agreement with Machlink, for wireless technology with high-speed Internet, phone and data applications 2IGEN Networks signs Exclusive Agreement with Machlink, for wireless technology with high-speed Internet, phone and data applications 3Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress 2Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress 3
(Date:3/23/2015)... 23, 2015 SoundView Technology Group issues a new ... NXTD ) Wocket smart wallet. SoundView was one of the selected ... experience with the Wocket in multiple scenarios and outlets. ... and other retailers, making both debit and credit card payments.  ... says, "If the company meets their plans in 2015, it ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... (Bronx, NY) Scientists at Albert Einstein College of ... Challenges Explorations (GCE) grants from the Bill & Melinda ... projects. The grant recipients are Arturo Casadevall , M.D., ... (TB), and Ekaterina Dadachova , Ph.D., and Joan Berman ...
... NASA satellite data and climate models have projected drier ... United States in coming decades. Other findings about U.S. ... the length and strength of fire seasons are expected ... Tuesday at the annual meeting of the American Geophysical ...
... Department of Energy,s Pacific Northwest National Laboratory will present ... American Geophysical Union Fall Meeting, which runs Monday, Dec. ... Center in San Francisco. Topics to be discussed include ... grow algae for biofuel and predicting the environmental impacts ...
Cached Biology News:Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB 2Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB 3Climate models project increase in US wildfire risk 2Climate models project increase in US wildfire risk 3Sunshine, biofuel and the tides, oh my! 2Sunshine, biofuel and the tides, oh my! 3
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
... in the Microsart e.motion are sterile-sealed, without protective ... specially designed individual package on a band. ... membrane filter units ensures that they are perfectly ... band guarantees uniform dispensing of the individual membrane ...
... PRKAR2 cAMP is a signaling molecule ... cAMP exerts its effects by activating the ... signal through phosphorylation of different target proteins. ... tetramer composed of two regulatory and two ...
... The model 55S Rocking Shaker provides ... and blotted membranes. The very slow ... degree of tilt provide a gentle ... over gels and blotted membranes to ...
Biology Products: